Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mouna Jandoubi
Observed names:
Jandoubi, Mouna <1996>,
M. Jandoubi
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
ORCID:
0000-0002-5774-7362
Observed ORCID:
0000-0002-5774-7362
OpenAlex ID:
A5020414573
Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon
2023
·
Andrea Ghelli Luserna di Rorà
, Mouna Jandoubi
, et al.
·
Molecules
·
19
PDF
Polyamines at the crossroad between cell metabolism and epigenetic regulation in acute leukemias
2025
·
Francesca Pirini
, Anna Ferrari
, et al.
·
Cell Death Discovery
·
15
PDF
Novel molecular mechanisms of FLT3 deregulation: from the acute myeloid leukemia experience to therapeutic insights in acute lymphoblastic leukemia
2025
·
F. Lo Schiavo
, C. Salvesi
, et al.
·
Molecular Cancer
·
13
PDF
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions
2024
·
Andrea Ghelli Luserna di Rorà
, Mouna Jandoubi
, et al.
·
Journal of Translational Medicine
·
7
PDF
Novel Mechanisms of Venetoclax Resistance in Acute Myeloid Leukemia Based on Genomic Rearrangements
2023
·
Irene Zacheo
, Anna Ferrari
, et al.
·
Blood
·
2
Omaveloxolone potentiates BET protein inhibition under hypoxia by disrupting metabolic and translational programs in acute myeloid leukemia cells
2026
·
Samantha Bruno
, Martina Ghetti
, et al.
·
Journal of Translational Medicine
Identifying novel therapeutic vulnerabilities of acute myeloid leukemia molecular subtypes
2026
·
Jandoubi, Mouna <1996>
·
AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
P451: Gene Fusions and Other Genomic Events Underlie Venetoclax and Hypomethylating Agent Resistance and Provide New Targets in Acute Myeloid Leukemia.
2023
·
Anna Ferrari
, Irene Zacheo
, et al.
·
HemaSphere
Abstract 3001: Targeting autophagy in acute lymphoblastic leukemia: Synergism between ponatinib, hydroxychloroquine and rapamycin
2022
·
Andrea Ghelli Luserna Di Rora
, Eugenio Fonzi
, et al.
·
Cancer Research
Show more works
View as search
Works count:
9
Citation count:
56
H-index:
4
I10-index:
3
Year
Topic
Type